 vitro activity vivo efficacy new series derivatives Analogs epimeric hydroxy amino substitution position macrolide ring amino epimeric hydroxy substitution position cladinose sugar attempt acid-stable derivatives erythromycin improved bioavailability activity gram-negative bacteria modifications compounds vitro activities similar erythromycin mice analogs active staphylococci streptococci Haemophilus influenzae Legionella pneumophila mice -amino -epiamino peak concentrations serum lung serum half-lives and/or areas serum curve erythromycin pharmacokinetics erythromycin vivo antibacterial activities compounds